Log In
Print this Print this

Elestat, epinastine HCl

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
Description0.5% epinastine HCL ophthalmic solution, antihistamine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAllergic conjunctivitis
Indication DetailsTreat allergic conjunctivitis
Regulatory Designation
PartnerAllergan plc;
Merck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today